Which treatment is right for you?
Cortisone is a symptom-management tool; stem cell therapy is a disease-modifying option. Used occasionally for flares, cortisone is reasonable. Used repeatedly, it is now associated with accelerated cartilage loss — and at that point, an MSC program is the more rational long-term choice.
Stem cell therapy is the better answer when:
- Patients with multiple prior cortisone shots
- Active cartilage loss on imaging
- Concern about long-term joint health
- Athletes and physically active patients
Cortisone (Corticosteroid) Injections is the better answer when:
- Acute, severe inflammatory flare
- Pre-surgical bridge for symptom control
- Bursitis or capsulitis (short-term use)
- Patients ineligible for regenerative therapy
What each option actually is
Wharton's Jelly stem cell therapy
Wharton's Jelly MSC therapy delivers living regenerative cells with anti-inflammatory and chondroprotective signalling. Unlike cortisone, it does not suppress the immune system or weaken local tissue.
Cortisone (Corticosteroid) Injections
Cortisone injections deliver a synthetic corticosteroid (e.g. triamcinolone, methylprednisolone) into the joint or soft tissue. It powerfully suppresses local inflammation for weeks to a few months. Repeated use is now restricted by most guidelines because of cartilage-thinning evidence (McAlindon JAMA 2017).
Side-by-side comparison
| Dimension | Stem cell therapy | Cortisone |
|---|---|---|
| Mechanism | Regenerative + immunomodulatory | Anti-inflammatory suppression |
| Effect on cartilage | Neutral-to-protective | Repeated use linked to cartilage loss |
| Speed of pain relief | 2–8 weeks (gradual) | 24–72 hours (fast) |
| Duration of benefit | 12–24 months reported | 6–12 weeks typically |
| Recommended frequency | 1 program, optional boosters | Limited to 3–4 lifetime per joint |
| Systemic side effects | Rare | Blood-sugar spikes, weight gain, immune suppression with repeats |
| Per-procedure cost | Higher | Very low |
| Use in pre-surgical bridge | Suboptimal use case | Excellent |
What patients actually pay
Stem cell therapy: €6,500–€12,000 program — typically lasts 12–24 months per cohort data.
Cortisone: $100–$400 per injection — typically lasts 6–12 weeks.
Realistic downtime
Stem cell therapy: 24–48h. NSAIDs restricted for 10–14 days.
Cortisone: Minimal — but with a known post-injection flare in ~10% of patients.
What the published evidence actually says
Recent randomized data (McAlindon et al., JAMA 2017) showed repeated intra-articular triamcinolone produced greater cartilage volume loss than saline over 2 years. We do not refuse to discuss cortisone — we just believe patients should know what the long-term trade-off is before agreeing to a third or fourth course.
Common questions when comparing these treatments
Are cortisone injections bad for my knees?
Single or occasional injections are generally safe and useful. Repeated injections (every few months for years) have been linked in randomized data to greater cartilage volume loss versus saline. Most guidelines now cap cortisone at 3–4 lifetime injections per joint.
Can I have stem cell therapy after cortisone?
Yes. We typically allow a 4–6 week washout after a cortisone injection before administering MSC therapy, so the steroid does not blunt the regenerative signalling.
Why is stem cell therapy more expensive?
It is a manufactured biological product (GMP-expanded cells with full characterization) rather than a generic synthetic drug. The upfront cost is higher; the duration of benefit and the absence of cartilage-loss trade-off are the value.
Does cortisone weaken the joint?
It can. Repeated steroid exposure is associated with chondrocyte apoptosis, weakened tendons, and accelerated cartilage volume loss in published RCT data.